Skip to main content
Glama

Sarb Za

by io.github.pipeworx-io

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
-  "company"
-]New value: +[
+  "company",
+  "ticker"
+]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. First observed

TDQS

A4.4/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already mark it read-only, idempotent, and non-destructive, and the description adds substantial behavioral detail beyond that: fan-out across multiple sources, soft-fail for patents, expected-empty fda_products for companies without biologics, sources_used/sources_failed semantics, private-company resolved:false behavior, and type interchangeability. Nothing contradicts the annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but front-loaded with the core routing message and most important behavior. The dense semicolon-separated return-field enumeration earns its place because there is no output schema, though it could be slightly better organized for scanning.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool's complexity and the absence of an output schema, the description is exceptionally complete. It documents inputs, output fields, failure semantics, edge cases, source fallbacks, and the private-company path, so an agent has what it needs to invoke the tool and interpret results correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so the baseline is 3. The description reinforces the schema by giving examples ("AAPL", "0000320193", "Moderna") and explaining that type accepts company/ticker interchangeably, but it adds limited new meaning beyond what the parameter descriptions already provide.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a specific verb and resource: it builds a full cross-source profile of a US public company in one parallel call. It clearly distinguishes itself from single-pack SEC/XBRL/news lookups by saying 'ALWAYS PREFER' for holistic views, so an agent can tell it apart from sibling tools.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly says when to use it: 'ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view.' It also gives concrete example user phrasings. It does not enumerate exclusions or alternatives by name, but the guidance is clear enough for routing.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Sarb Za toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.9/5.0
Disambiguation2/5

Several tools have overlapping or redundant purposes, most notably ask_pipeworx and ask_pipeworx_beta (currently identical), and the cluster of Polymarket tools (polymarket_edges, polymarket_arbitrage, bet_research) which all surface trading opportunities. While the lengthy descriptions help, an agent could easily select the wrong tool.

Naming Consistency4/5

All tool names use snake_case with a readable verb/noun structure, and there are no casing inconsistencies. However, the verb-first vs noun-first pattern is not uniformly applied (e.g., ask_pipeworx vs sarb_timeseries vs polymarket_edge_tracker), so it's mostly consistent with minor deviations.

Tool Count2/5

At 36 tools, the set is large and exceeds the 25-tool threshold; the broad scope justifies some volume but the presence of duplicate/overlapping tools (ask_pipeworx_beta, multiple Polymarket scanners) makes the count feel inflated.

Completeness4/5

The set covers a wide domain — SARB data, company research, prediction markets, AI visibility, memory, and subscriptions — with a good lifecycle for most features. Minor gaps exist (no subscription update, no bulk data export), but the core workflows are well covered.

Resources